Two advances in the management of Parkinson disease

Erwin B. Montgomery, Jr., MD
Co-Director, Center for Functional and Restorative Neuroscience; Departments of Neurology and Neuroscience, Lerner Research Center, The Cleveland Clinic

Address: Erwin B. Montgomery, Jr., MD, Departments of Neurology and Neuroscience, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Montgomery has indicated that he has received grant or research support from Medtronic, Inc., serves as a consultant for Medtronic, Inc., and is on the speakers’ bureaus of the Medtronic, GlaxoSmithKline, and Pharmacia corporations.

This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Erwin B. Montgomery, Jr., MD
Co-Director, Center for Functional and Restorative Neuroscience; Departments of Neurology and Neuroscience, Lerner Research Center, The Cleveland Clinic

Address: Erwin B. Montgomery, Jr., MD, Departments of Neurology and Neuroscience, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Montgomery has indicated that he has received grant or research support from Medtronic, Inc., serves as a consultant for Medtronic, Inc., and is on the speakers’ bureaus of the Medtronic, GlaxoSmithKline, and Pharmacia corporations.

This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Erwin B. Montgomery, Jr., MD
Co-Director, Center for Functional and Restorative Neuroscience; Departments of Neurology and Neuroscience, Lerner Research Center, The Cleveland Clinic

Address: Erwin B. Montgomery, Jr., MD, Departments of Neurology and Neuroscience, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Dr. Montgomery has indicated that he has received grant or research support from Medtronic, Inc., serves as a consultant for Medtronic, Inc., and is on the speakers’ bureaus of the Medtronic, GlaxoSmithKline, and Pharmacia corporations.

This paper discusses therapies that are investigational or are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.